News | September 16, 2025
Alembic Pharmaceuticals receives EIR for API - I and API - II facility located at Panelav
The inspection was carried out between May 26, 2025 and May 31, 2025
The inspection was carried out between May 26, 2025 and May 31, 2025
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
Raludotatug deruxtecan is a specifically engineered, potential first-in-class CDH6-directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo
The hospital was recognised as a Winner (Medium) in the category of Best Academic Institution (Government/Private)
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
We are taking Ayurveda to the world as a sustainable healthcare solution: Union Minister Prataprao Jadhav
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
Subscribe To Our Newsletter & Stay Updated
